Vir Biotechnology, Inc. (VIR) Operating income 2017–2025
Vir Biotechnology, Inc. (VIR) annual operating income history from SEC filings — each fiscal year as reported.
-$479.3MFY2025 · since FY2017: -$81.5M → -$479.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$479.3M | +18.4% |
| FY2024 | -$587.2M | +14.2% |
| FY2023 | -$684.3M | -182.1% |
| FY2022 | $833.1M | +98.0% |
| FY2021 | $420.8M | +241.7% |
| FY2020 | -$297.0M | -66.9% |
| FY2019 | -$178.0M | -50.0% |
| FY2018 | -$118.7M | -45.6% |
| FY2017 | -$81.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice